Article Information
History
- September 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Department of Clinical Pharmacy, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, 1985 Zonal Ave, Los Angeles, CA 90033, USA
- 2Department of Regulatory and Quality Sciences, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, 1985 Zonal Ave, Los Angeles, CA 90033, USA
- 3USC Anton Yelchin CF Clinic, 1510 San Pablo St, Los Angeles, CA 90033, USA
- ↵*Corresponding author: 1985 Zonal Avenue, Los Angeles, CA 90033, USA, Tel: 323-442-1402, Fax: 323-442-1395, Email: beringer{at}usc.edu
Posted September 17, 2023.
Drug-induced liver injury associated with elexacaftor/tezacaftor/ivacaftor from the FDA Adverse Event Reporting System (FAERS)
